Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Cash Flow Reinvestment Rate
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow Reinvestment Rate of 1.33x as of September 2025, reinvesting CN¥17.49 Million (capex CN¥17.49 Million ) from operating cash flow of CN¥13.19 Million. See cash generation quality of Tianjin Tianyao Pharmaceuticals Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2000–2024)
Historical reinvestment intensity for Tianjin Tianyao Pharmaceuticals Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Tianjin Tianyao Pharmaceuticals Co Ltd.
Annual Cash Flow Reinvestment Rate for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year capital reinvestment analysis for Tianjin Tianyao Pharmaceuticals Co Ltd. See 600488 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥153.93 Million | CN¥569.37 Million | CN¥77.74 Million | ▲ +59.0% |
| 2023 | 0.17x | CN¥133.15 Million | CN¥783.01 Million | CN¥133.15 Million | ▼ -72.2% |
| 2022 | 0.61x | CN¥400.33 Million | CN¥653.52 Million | CN¥202.20 Million | ▼ -74.0% |
| 2021 | 2.36x | CN¥747.80 Million | CN¥316.89 Million | CN¥370.84 Million | ▼ -21.5% |
| 2020 | 3.01x | CN¥1.04 Billion | CN¥346.88 Million | CN¥458.51 Million | ▲ +200.2% |
| 2019 | 1.00x | CN¥279.74 Million | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.0% |
| 2018 | 1.08x | CN¥203.88 Million | CN¥189.27 Million | CN¥203.58 Million | ▼ -68.2% |
| 2016 | 3.39x | CN¥214.78 Million | CN¥63.32 Million | CN¥64.78 Million | ▲ +125.9% |
| 2015 | 1.50x | CN¥194.48 Million | CN¥129.50 Million | CN¥45.32 Million | ▲ +1499.9% |
| 2014 | 0.09x | CN¥16.78 Million | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥310.08 Million | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥75.59 Million | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥62.76 Million | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥147.76 Million | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥202.32 Million | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥357.63 Million | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥224.74 Million | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥70.91 Million | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥133.47 Million | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥174.24 Million | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥171.20 Million | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥48.57 Million | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥36.29 Million | CN¥41.06 Million | CN¥36.29 Million | — |